← Back to JANX

Janux Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 08/05/2025
$10$3.7$10$0$0$0.4$8.9$1.3
−$22−$24−$24−$34−$24−$28−$6−$15
−$0.35−$0.39−$0.39−$0.55−$0.38−$0.51−$0.11−$0.30
6363626262555449

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.